MRI对比CT在评估含脂胸部病变中的诊断价值
本文综述了胸部含脂病变(纵隔、肺、胸膜或胸壁)的CT与MRI表现,指出CT仅能检出宏观脂肪,而MRI利用频谱和化学位移脂肪抑制技术可识别宏观和微观脂肪,从而提高无创诊断能力并避免电离辐射。
要点
- MRI可识别微观或体素内脂肪,而CT不能,有助于诊断含微观脂肪的胸部病变。
- 频谱和化学位移脂肪抑制技术是MRI评估含脂病变的关键序列。
- 对于CT上未显示宏观脂肪的胸部病变,MRI可提供额外诊断信息。
关键影像表现/征象
- 胸部含脂病变可起源于纵隔、肺、胸膜或胸壁。
- CT仅能在病变含宏观脂肪时帮助检出和诊断。
- MRI采用频谱和化学位移脂肪抑制技术可识别宏观和微观脂肪。
临床应用与阅片要点
- 对于CT怀疑含脂但未显示宏观脂肪的胸部病变,建议补充MRI以评估微观脂肪。
- 阅片时注意结合频谱和化学位移脂肪抑制序列判断病变内脂肪成分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Intrathoracic fat-containing lesions may arise in the mediastinum, lungs, pleura, or chest wall. While CT can be helpful in the detection and diagnosis of these lesions, it can only do so if the lesions contain macroscopic fat. Furthermore, because CT cannot demonstrate microscopic or intravoxel fat, it can fail to identify and diagnose microscopic fat-containing lesions. MRI, employing spectral and chemical shift fat suppression techniques, can identify both macroscopic and microscopic fat, with resultant enhanced capability to diagnose these intrathoracic lesions non-invasively and without ionizing radiation. This paper aims to review the CT and MRI findings of fat-containing lesions of the chest and describes the fat-suppression techniques utilized in their assessment.
引用
- Hochhegger, Zanon, Patel, et al. The diagnostic value of magnetic resonance imaging compared to computed tomography in the evaluation of fat-containing thoracic lesions. Br J Radiol. 2022. PMID: 36125174. doi:10.1259/bjr.20220235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。